Glycocalyx Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Glycocalyx Therapeutics General Information
Description
Developer of transformative intratumoral pan-cancer therapies designed to target the tumor microenvironment. The company specializes in removing barriers and inducing intratumoral immune architecture for effective full-circle immunotherapy, enabling medical professionals to create a protective layer of the vascular system and prevent organ damage in conditions like sepsis or diabetes.
Contact Information
Corporate Office
- C/O Switzerland Innovation Park Basel Area AG
- Hegenheimermattweg 167a
- 4123 Allschwil
- Switzerland
Corporate Office
- C/O Switzerland Innovation Park Basel Area AG
- Hegenheimermattweg 167a
- 4123 Allschwil
- Switzerland
Glycocalyx Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2022 | Completed | Startup |
Glycocalyx Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Glycocalyx Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Glycocalyx Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovation Office (Accelerator/Incubator) | Accelerator/Incubator | |||
| University of Basel | University |
Glycocalyx Therapeutics FAQs
-
When was Glycocalyx Therapeutics founded?
Glycocalyx Therapeutics was founded in 2022.
-
Where is Glycocalyx Therapeutics headquartered?
Glycocalyx Therapeutics is headquartered in Allschwil, Switzerland.
-
What is the size of Glycocalyx Therapeutics?
Glycocalyx Therapeutics has 2 total employees.
-
What industry is Glycocalyx Therapeutics in?
Glycocalyx Therapeutics’s primary industry is Biotechnology.
-
Is Glycocalyx Therapeutics a private or public company?
Glycocalyx Therapeutics is a Private company.
-
What is Glycocalyx Therapeutics’s current revenue?
The current revenue for Glycocalyx Therapeutics is .
-
Who are Glycocalyx Therapeutics’s investors?
Innovation Office (Accelerator/Incubator) and University of Basel have invested in Glycocalyx Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
